Latin American technology business leader and former Rappi CEO Sérgio Saraiva Pontes has joined the board of MedPass Brazil – reflecting MedPass’s fast emergence and significant international potential.
Pontes will serve as Chairman of the MedPass board’s Operations Committee, and continues as an investor and partner at Rappi – which is backed by such investors as Softbank and Sequoia and defined, according to Wikipedia, “as the Latin American SuperApp and one of the fastest growing companies in the region.” It operates today in nine countries and 200+ cities.
In his distinguished career, Pontes has founded and managed several startups and served Grupo Ambev Anheuser-Busch for 20 years.
“With his exceptional background, Sérgio knows how to provide the necessary leadership when tackling pivotal strategic business and operational issues,” said MedPass co-founder Michael Luzich.
Pontes’ accession to the MedPass board represents another key milestone for the company’s development: MedPass is currently among the 10 most highly capitalized businesses within a universe of more than 800 startups in the Brazilian healthcare sector, according to Crunchbase.
At a time when fast, reliable health monitoring may be a matter of life or death, the MedPass platform is addressing a critical marketplace need.
MedPass uses data intelligence to promote predictive healthcare and offers an individualized counseling plan as well as appointment scheduling with access to individual medical histories by healthcare professionals.
A totally new and innovative initiative is the integration of its services as “embedded solutions” in digital communication with B2B2C customers, so as to support retention of, and motivation by, customers and service providers.
Such verticals as “My Doctor” and “My Psychologist” ensure the member always talks to the same doctor or psychologist, instead of being randomly directed to another healthcare professional like other companies. When contacting via chat or video, healthcare professionals have immediate access to the medical history and risk profile on their dashboards, saving precious time and focusing care on what the individual really needs at that moment.
The Mental Health vertical and the recently launched women’s health vertical have grown significantly considering the current challenges of dealing with the impact of COVID-19 on social, family, and professional lives.
The global mHealth apps industry is projected to surge at a compound annual growth rate of 34.8% between 2021 and 2028.